Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Serotonin revisited.

Cowen PJ, Lucki I.

Psychopharmacology (Berl). 2011 Feb;213(2-3):167-9. doi: 10.1007/s00213-010-2138-7. Epub 2010 Dec 22. No abstract available.

PMID:
21181118
2.

The 5-HT3 receptor in mammalian brain: a new target for the development of psychotropic drugs?

Apud JA.

Neuropsychopharmacology. 1993 Feb;8(2):117-30. Review. No abstract available.

3.

Brain 5-hydroxytryptamine metabolism: adaptive changes after long-term administration of psychotropic drugs.

Rastogi RB, Singhal RL.

Gen Pharmacol. 1978;9(5):307-14. Review. No abstract available.

PMID:
359406
4.

Relevance of 5-HT autoreceptors for psychotropic drug action.

Göthert M, Schlicker E.

Psychopharmacol Ser. 1993;10:38-51. Review. No abstract available.

PMID:
8361981
5.

Use of serotonergic agents in the clinical assessment of central serotonin function.

Murphy DL, Mueller EA, Garrick NA, Aulakh CS.

J Clin Psychiatry. 1986 Apr;47 Suppl:9-15. Review.

PMID:
3514586
6.
7.

Serotonin and anxiety revisited.

Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G.

Biol Psychiatry. 1988 Jan 15;23(2):189-208. Review. No abstract available.

PMID:
3275471
8.

[Current concepts of the effects of neuroleptics].

Kostowski W, Płaźnik A.

Psychiatr Pol. 1990 Sep-Oct;24(5):28-37. Review. Polish. No abstract available.

PMID:
1983397
9.

5-hydroxytryptamine metabolism in the brain under the influence of psychotropic drugs.

Herman ZS.

Pol J Pharmacol Pharm. 1975 Oct;27(Suppl):25-43. Review. No abstract available.

PMID:
128747
10.

Presynaptic receptors. Relevance to psychotropic drug action in man.

Meltzer HY.

Ann N Y Acad Sci. 1990;604:353-71. Review. No abstract available.

PMID:
1977354
11.

[New discoveries on antidepressive treatment: serotonin is the key].

Evenden J.

Lakartidningen. 1997 Sep 17;94(38):3262-6. Review. Swedish. No abstract available.

PMID:
9379793
12.

Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.

Di Giovanni G, Di Matteo V, Esposito E.

Indian J Exp Biol. 2002 Dec;40(12):1344-52. Review.

PMID:
12974395
13.

[Serotonin receptors as a target for new drugs].

Franck J, Fried G.

Lakartidningen. 1990 Dec 19;87(51-52):4417-9. Review. Swedish. No abstract available.

PMID:
2273921
14.

Receptor adaptations to centrally acting drugs.

Creese I, Sibley DR.

Annu Rev Pharmacol Toxicol. 1981;21:357-91. Review. No abstract available.

PMID:
6263174
15.

5-HT receptor sub-types: aspects of their regulation and function.

Elliott JM, Flanigan TP, Newberry NR, Zetterström T, Leslie RA.

Neurochem Int. 1994 Dec;25(6):537-43. Review. No abstract available.

PMID:
7894330
16.
17.

Astroglial 5-HT1a receptors and S-100 beta in development and plasticity.

Whitaker-Azmitia PM, Azmitia EC.

Perspect Dev Neurobiol. 1994;2(3):233-8. Review.

PMID:
7850356
18.

Alterations of serotonin transmission in schizophrenia.

Abi-Dargham A.

Int Rev Neurobiol. 2007;78:133-64. Review.

PMID:
17349860
19.

Recent advances in khat research.

Kalix P.

Alcohol Alcohol. 1984;19(4):319-23. Review.

PMID:
6398076
20.

Serotonin receptors in the brain.

Haigler HJ, Aghajanian GK.

Fed Proc. 1977 Jul;36(8):2159-64. Review. No abstract available.

PMID:
326580

Supplemental Content

Support Center